You are here

Vascular & Endovascular


The FDA on Feb. 15 announced Stryker’s Trevo Retriever clot-removal device can be used up to 24 hours after stroke onset, mirroring the American Heart Association and American Stroke Association’s recently updated guidelines expanding the window for mechanical thrombectomy from 6 to 24 hours.

The FDA cleared’s clinical support tool on Feb. 13, allowing the software that alerts clinicians to the possibility of a stroke to be marketed in the United States.

Short kids grow up to have a higher risk of stroke, according to a study of more than 310,000 Danish schoolchildren with up to eight decades of follow-up.

A team of researchers has developed a risk score containing five readily available factors that predict the odds of stroke for heart attack patients with reduced ejection fraction but without atrial fibrillation (AFib).

People who have migraines are more at risk than the general population for a range of adverse cardiovascular events, according to a study published in The BMJ.


Recent Headlines

Spinal cord injury affects heart function

Spinal cord injuries (SCIs) directly affect the heart, but the extent of any damage done is reliant on the severity of an SCI, new research out of the University of British Columbia, Canada, states.

FDA approves trial to test percutaneous procedure for PAD

PQ Bypass has received an investigational device exemption from the FDA to initiate the first pivotal clinical trial of percutaneous femoropopliteal bypass for patients with peripheral artery disease (PAD), according to a press release.

Living near busy roads could have serious coronary, vascular consequences

Heart patients could be at an increased risk for peripheral artery disease and hypertension if they live near a busy road, Duke University researchers reported in the American Heart Association journal Arteriosclerosis, Thrombosis and Vascular Biology this week.

Elevated UACR means not just kidney disease, but increased CVD risk in diabetes patients

Elevated levels of UACR in type 2 diabetes patients at high cardiovascular risk are linked to increased risks for all-cause death and adverse cardiovascular outcomes, researchers reported this week in JAMA Cardiology.

Pollution can ruin cardiorespiratory benefit of exercise

Striding down a polluted street is no walk in the park when it comes to the benefits of light exercise, new research suggests.

18% of PAD patients readmitted within 30 days of revascularization

More than one in six patients with peripheral arterial disease (PAD) who undergo revascularization procedures to restore blood flow to blocked arteries are readmitted to the hospital within 30 days, according to research published Dec. 5 in the Annals of Internal Medicine.

Contrary to CREST results, carotid stenting has increased in older patients

A new study published in JAMA Neurology suggests clinicians have opted to perform carotid artery stenting (CAS) more often since the CREST trial has been published, even in patient populations for which the trial demonstrated the benefit of carotid endarterectomy (CEA).

One workout may provide immediate protection to heart

A new review published in JAMA Cardiology suggests a single workout can protect the heart from ischemia for up to several days.

Cannabis-like drug 1st pill to successfully treat sleep apnea

The largest, longest trial to date testing an oral drug for obstructive sleep apnea yielded positive results, according to research out of Chicago. Dronabinol—a synthetic THC substitute—proved helpful in reducing apnea and decreasing sleepiness in 73 adult patients.

VR on par with traditional rehab in restoring motor function in stroke patients

Using virtual reality training to restore motor function after a stroke is just as effective as traditional physical therapy, reports a new study published in the medical journal Neurology.